LINC 2022: PRIZER Study With Dr Deloose: Renzan™ Stent in Pts With PAD

Подробнее о видео

Watch on Radcliffe Vascular:

Dr Koen Deloose (AZSint Blasius Hospital Dendermonde, BE) joins us at LINC 2022 to discuss the outcomes of the PRIZER study. This was a prospective multicenter study aiming to confirm the safety and efficacy of Terumo's Renzan™ Peripheral Stent System in patients with superficial femoral and/or popliteal artery disease.

Discussion Points:
1. Renzan™ Peripheral Stent System
2. Patient Population, Inclusion Criteria and Study Design
3. Key Results
4. Influence on Practice
5. Further Study and Next Steps

Recorded on-site at LINC 2022, Liepzig.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.